FIELD: pharmaceutics.
SUBSTANCE: invention relates to pharmacy, pharmacology and emergency medical care and can be used as an alternative to ECMO for immediate elimination of suffocation and hypoxemia, caused by bronchial asthma, COVID-19, purulent obstructive bronchitis, drowning or inhalation injury, in order to prevent hypoxic brain cell damage and human death. Invention consists in the fact that the solution has a volume of not less than 31 ml, is heated to a temperature of +45 °C, contains 4.5% hydrogen peroxide, 1.8% sodium bicarbonate and oxygen to create an excess pressure of 0.3 atm at +8 °C.
EFFECT: proposed agent provides rapid filling of airways with oxygen gas immediately after intrapulmonary injection, immediate intensive absorption of oxygen into blood through lungs, elimination of hypoxemia and restoration of lost consciousness without cauterizing action on mucous membranes of airways.
1 cl
Title | Year | Author | Number |
---|---|---|---|
WARM ALKALINE SOLUTION OF HYDROGEN PEROXIDE FOR INTRAPULMONARY INJECTION | 2023 |
|
RU2807851C1 |
AEROSOL FOR INVASIVE MECHANICAL VENTILATION IN COVID-19 | 2020 |
|
RU2742505C1 |
ARTIFICIAL SPUTUM FOR MODELING RESPIRATORY OBSTRUCTION IN COVID-19 | 2021 |
|
RU2748999C1 |
LYMPHO-SUBSITUTE FOR LOCAL MAINTAINING VIABILITY OF ORGANS AND TISSUES IN HYPOXIA AND ISCHEMIA | 2015 |
|
RU2586292C1 |
MEANS FOR PHYSICAL ENDURANCE INCREASE | 2016 |
|
RU2634271C1 |
AGENT FOR INCREASING RESISTANCE TO HYPOXIA | 2015 |
|
RU2604129C2 |
MEANS FOR EMERGENCY VOICE RECOVERY AT FLASH APHONIA | 2016 |
|
RU2625766C1 |
GEL FOR CHILDREN'S SKIN | 2019 |
|
RU2713943C1 |
ENERGY DRINK | 2016 |
|
RU2639493C1 |
BLEACHING CLEANSER OF DENTURES | 2017 |
|
RU2659952C1 |
Authors
Dates
2024-12-16—Published
2023-11-02—Filed